Anja Kathrin Wege

10PUBLICATIONS
22CO-AUTHORS
Haematological tumoursMolecular targetsTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 07, 2025
Detection of Human Circulating and Extracellular Vesicle-Derived miRNAs in Serum of Humanized Mice Transplanted with Human Breast Cancer (HER2+ and TNBC) Cells-A Proof of Principle Investigation.

I-Peng Chen, Stefan Henning, Marc Bender

|Jul 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice.

Veruschka Albert, Christina Bruss, Deniz Tümen

|May 13, 2023
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion.

Christina Bruss, Kerstin Kellner, Veruschka Albert

|May 14, 2022
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice.

Christina Bruss, Kerstin Kellner, Olaf Ortmann

|Dec 10, 2021
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma.

Daniela Schulz, Martin Wetzel, Jonas Eichberger

|Jun 02, 2021
CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM).

Anja Kathrin Wege, Tobias F Dreyer, Attila Teoman

Pageof 2

Frequent Collaborators

4 joint publications

Gero Brockhoff

3 joint publications

James A Hutchinson

1 joint publications

Paloma Riquelme

1 joint publications

Lisa Walter